CORSAIR CAPITAL MANAGEMENT, L.P.
Position in RNTX — Rein Therapeutics, Inc.
CIK 1276470
NEW YORK, NY
Position in RNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$83,200
New position
Shares Held
80,000
first reported quarter
Ownership
0.093%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 59 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026CORSAIR CAPITAL MANAGEMENT, L.P. holds $1,622,400 across 2 Biotechnology names. RNTX ranks #2 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IOVA |
Iovance Biotherapeutics, Inc.
|
370,000 | $1,539,200 | |
| 2 | RNTX |
Rein Therapeutics, Inc.
This page
|
80,000 | $83,200 |
All Filings in RNTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,200 | 80,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||